Elba M. Hadden

2.5k total citations
50 papers, 1.8k citations indexed

About

Elba M. Hadden is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Elba M. Hadden has authored 50 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 11 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in Elba M. Hadden's work include Immune Cell Function and Interaction (12 papers), Cytomegalovirus and herpesvirus research (9 papers) and T-cell and B-cell Immunology (7 papers). Elba M. Hadden is often cited by papers focused on Immune Cell Function and Interaction (12 papers), Cytomegalovirus and herpesvirus research (9 papers) and T-cell and B-cell Immunology (7 papers). Elba M. Hadden collaborates with scholars based in United States and Mexico. Elba M. Hadden's co-authors include John W. Hadden, Ronald G. Coffey, Elliott Middleton, Mari K. Haddox, Nelson D. Goldberg, John R. Sadlik, J.L. Touraine, R A Good, F. Touraine and Richard D. Estensen and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Elba M. Hadden

50 papers receiving 1.6k citations

Peers

Countries citing papers authored by Elba M. Hadden

Since Specialization

Citations

This map shows the geographic impact of Elba M. Hadden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elba M. Hadden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elba M. Hadden more than expected).

Fields of papers citing papers by Elba M. Hadden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elba M. Hadden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elba M. Hadden. The network helps show where Elba M. Hadden may publish in the future.

Co-authorship network of co-authors of Elba M. Hadden

This figure shows the co-authorship network connecting the top 25 collaborators of Elba M. Hadden. A scholar is included among the top collaborators of Elba M. Hadden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elba M. Hadden. Elba M. Hadden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	IRX‐2 and Thymosin α1 (Zadaxin) Increase T Lymphocytes in T Lymphocytopenic Mice and Humans 2007 ·Annals of the New York Academy of Sciences ·John W. Hadden, Emma Verástegui, Elba M. Hadden	12
2	A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck 2003 ·International Immunopharmacology ·John W. Hadden, Emma Verástegui, José Luís Barrera, Michael R. Kurman, Abelardo Meneses, Juan W Zinser, Horacio Astudillo‐de la Vega, Elba M. Hadden	28
3	Immunotherapy with natural interleukins and/or thymosin α1 potently augments T-lymphocyte responses of hydrocortisone-treated aged mice 1995 ·International Journal of Immunopharmacology ·John W. Hadden, (unknown), (unknown), Elba M. Hadden	24
4	Methyl inosine monophosphate (MIMP) augments T-lymphocyte mitogen responses and reverses various immunosuppressants 1995 ·International Journal of Immunopharmacology ·Elba M. Hadden, (unknown), (unknown), Ronald G. Coffey, Alfredo Giner‐Sorolla, John W. Hadden	4
5	Interleukins and Contrasuppression Induce Immune Regression of Head and Neck Cancer 1994 ·Archives of Otolaryngology - Head and Neck Surgery ·John W. Hadden, (unknown), Paul Baekey, Paul L. Skipper, Elba M. Hadden	55
6	Immunopharmacologic Properties of Inosine 5'‐Methyl Monophosphate (MIMP) 1993 ·Annals of the New York Academy of Sciences ·(unknown), (unknown), Alfredo Giner‐Sorolla, Elba M. Hadden, John W. Hadden	7
7	Mixed interleukins and thymosin fraction V synergistically induce T lymphocyte development in hydrocortisone-treated aged mice 1992 ·Cellular Immunology ·Elba M. Hadden, (unknown), (unknown), John W. Hadden	17
8	Interleukin 1 regulates secretion of zinc-thymulin by human thymic epithelial cells and its action on T-lymphocyte proliferation and nuclear protein kinase C. 1992 ·Proceedings of the National Academy of Sciences ·(unknown), Elba M. Hadden, Marie D. Sauro, (unknown), John W. Hadden	68
9	Thymic Involution in Aging Prospects for Correction 1992 ·Annals of the New York Academy of Sciences ·John W. Hadden, (unknown), (unknown), Elba M. Hadden	29
10	Potentiation of immune responses in mice by a new inosine derivative—Methyl inosine monophosphate (MIMP) 1992 ·International Journal of Immunopharmacology ·(unknown), Anutosh Ranjan Saha, Yulai Wang, (unknown), Alfredo Giner‐Sorolla, Elba M. Hadden, John W. Hadden	8
11	Methyl inosine monophosphate: A potential immunotherapeutic for early human immunodeficiency virus (HIV) infection 1992 ·International Journal of Immunopharmacology ·John W. Hadden, Joseph Ongrádi, (unknown), Robert Nelson, (unknown), Craig Monell, Mette Strand, Alfredo Giner‐Sorolla, Elba M. Hadden	12
12	Methyl inosine monophosphate (MIMP), a new purine immunomodulator for HIV infection 1991 ·International Journal of Immunopharmacology ·John W. Hadden, Alfredo Giner‐Sorolla, Elba M. Hadden	11
13	A pituitary factor induces thymic epithelial cell proliferation in vitro 1989 ·Brain Behavior and Immunity ·John W. Hadden, Anne Galy, Harry Chen, Elba M. Hadden	10
14	Thymosin, interleukins, isoprinosine and imuthiol do not reconstitute T-cells in athymic nude mice 1989 ·International Journal of Immunopharmacology ·John W. Hadden, (unknown), (unknown), (unknown), R. A. Wolstencroft, Elba M. Hadden	7
15	Therapy of secondary T-cell immunodeficiencies with biological substances and drugs 1989 ·Medical Oncology and Tumor Pharmacotherapy ·John W. Hadden, Elba M. Hadden	4
16	Strategies of immune reconstitution: Effects of lymphokines on murine T cell development in vitro and in vivo 1989 ·Life Sciences ·John W. Hadden, (unknown), (unknown), Anne Galy, Elba M. Hadden	14
17	Interleukin II increases cyclic GMP levels in immature thymocytes and mitogen-primed T-lymphocytes 1987 ·International Journal of Immunopharmacology ·John W. Hadden, Elba M. Hadden, Ronald G. Coffey	7
18	Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation. 1977 ·The Journal of Experimental Medicine ·J.L. Touraine, John W. Hadden, F. Touraine, Elba M. Hadden, Richard D. Estensen, R A Good	169
19	LEVAMISOLE AND INOSIPLEX: ANTIVIRAL AGENTS WITH IMMUNOPOTENTIATING ACTION * 1977 ·Annals of the New York Academy of Sciences ·John W. Hadden, Carlos López, Richard J. O’Reilly, Elba M. Hadden	50
20	Guanosine 3′:5′-Cyclic Monophosphate: A Possible Intracellular Mediator of Mitogenic Influences in Lymphocytes 1972 ·Proceedings of the National Academy of Sciences ·John W. Hadden, Elba M. Hadden, Mari K. Haddox, Nelson D. Goldberg	277

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact